Inhibition of Steroidogenesis in Prostate Cancer Cells by Both a Natural and Another Synthetic Steroid
Drug Development Research · 2025-04 · 86 (2)
DOI: 10.1002/ddr.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 24.03.2025. Verfasst von Marisa Cabeza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Sistemas Biológicos y de Producción Agrícola y Animal, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Sitosterols, Androgens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was conducted with funds approved by the Universidad Autónoma Metropolitana-Xochimilco..
Abstract (Originalsprache)
Studies suggest that vegetarians and Asians have lower mortality rates from prostate cancer compared to men who follow a Western diet. β‐sitosterol, a key compound of plant‐based diets, has been found to induce significant changes in the ultrasonic structure of the prostatic adenomas, making it a promising candidate for further prostate cancer research. Consequently, we investigated the potential of β‐sitosterol and the synthetic derivative 2 as potent inhibitors of androgen synthesis, a critical process for the growth and survival of prostate tumor LNCaP cells. Solubilized LNCaP microsomes were used as a source of SRD5A1 and AKR1C3 to monitor androgen synthesis from labeled androstenedione, both in the presence and absence of β‐sitosterol or 2 . Furthermore, the effect of these steroids on LNCaP viability was determined using the MTT method. Our findings revealed significant insights into the androgen synthesis pathways in LNCaP cells. The most efficient metabolic route for dihydrotestosterone formation was the conversion of androstenedione to 5α‐androstanedione rather than from testosterone in LNCaP. This conclusion is supported by the Vmax values for 5α‐androstanedione formation (271.05 ± 5.0 ng/mg protein/min) and the Vmax of testosterone formation (80.1 ± 8.0 ng/mg protein/min). Both β‐sitosterol and 2 demonstrated substantial inhibitory effects of these enzymes for dihydrotestosterone formation and significantly reduced cell viability, highlighting their therapeutic potential. These findings enhance our understanding of the inhibitory effects of β‐sitosterol and 2 on LNCaP cells and suggest their promising application in the treatment of prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Sistemas Biológicos y de Producción Agrícola y Animal, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico.
- Laboratorio de Oncogenómica, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
ORCID-Profile: Marisa Cabeza
Förderung
- This study was conducted with funds approved by the Universidad Autónoma Metropolitana-Xochimilco.
Zitieren
APA
Cabeza, M., Mejía, K., García, F., Heuze, I., Morales, M., & Rodríguez-Dorantes, M. (2025). Inhibition of Steroidogenesis in Prostate Cancer Cells by Both a Natural and Another Synthetic Steroid. Drug Development Research, 86(2). https://doi.org/10.1002/ddr.70078
Vancouver
Cabeza M, Mejía K, García F, Heuze I, Morales M, Rodríguez-Dorantes M. Inhibition of Steroidogenesis in Prostate Cancer Cells by Both a Natural and Another Synthetic Steroid. Drug Development Research. 2025;86(2). doi:10.1002/ddr.70078
BibTeX
@article{Cabeza2025,
author = {Cabeza, Marisa and Mejía, Karla and García, Fernando and Heuze, Ivonne and Morales, Miguel and Rodríguez-Dorantes, Mauricio},
title = {Inhibition of Steroidogenesis in Prostate Cancer Cells by Both a Natural and Another Synthetic Steroid},
journal = {Drug Development Research},
year = {2025},
volume = {86},
number = {2},
doi = {10.1002/ddr.70078}
}
EUVIMED